Profund Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Profund Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,460	Closed	-$282K	–	1037
2022 Q3	$282K	Buy	+5,460	New	+$226K	0.02%	613
2021 Q2	–	Sell	-4,790	Closed	-$245K	–	1440
2021 Q1	$245K	Buy	4,790 +291	+6%	+$17.5K	0.01%	1139
2020 Q4	$279K	Buy	4,499 +241	+6%	+$13.8K	0.01%	864
2020 Q3	$233K	Buy	+4,258	New	+$229K	0.01%	797

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Profund Advisors's CCXI Position: Q4 2022 in Review

Profund Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 5,460 shares — an estimated $282K sold.

Profund Advisors first reported a position in CCXI in Q3 2020 and held it in 4 quarters. The position peaked at $282K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Profund Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Profund Advisors sold 5,460 ChemoCentryx, Inc. shares in Q4 2022, an estimated $282K.
Profund Advisors first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 4 quarters.
Profund Advisors's ChemoCentryx, Inc. position peaked at $282K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Profund Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.